BioInvent initiates subcutaneous arm of Phase 1/2 trial with BI-1206 ...
BioInvent initiates subcutaneous arm of Phase 1/2 trial with BI-1206 ...
Source: pr-inside.com
Page 48 - Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Merck Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Merck Sharp Today - Breaking & Trending Today
Clinical Trial: Pembrolizumab-Vibostolimab Coformulation in Metastatic NSCLC
Researchers are comparing a coformulation of pembrolizumab and vibostolimab to pembrolizumab alone for PD-L1-positive, metastatic NSCLC.
Source: cancertherapyadvisor.com
Single-Tablet Regimen Well Tolerated for HIV Post-Exposure Prophylaxis
Nonoccupational PEP with DOR/3TC/TDF following HIV exposure was well tolerated and associated with high treatment adherence.
Source: clinicaladvisor.com
Clinical Trial: Pembrolizumab Plus Chemo in HR+, ​HER2- Advanced Breast Cancer
Researchers are evaluating pembrolizumab plus investigator’s choice of chemotherapy in HR+, HER2- advanced breast cancer.
Source: cancertherapyadvisor.com
Propulsion of Sarcopenia Clinical Trial Pipeline as Novel and Extensive 10+ Therapies Likely to Enter in the Domain | DelveInsight
(Albany, United States) As per DelveInsight’s assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis
Source: benzinga.com